TGA, Australia's drug regulator, has issued a 2-year provisional approval for Tozinameran (BNT/Pfizer vaccine) from age 16, & released its 42-page assessment report tga.gov.au/auspar/auspar-… ...1/n
...One of the conditions is TGA approval of at least 20 vials from each batch before release...2/n
..Study of reproductive safety in rats has been completed & found no signs of concern related to pregnancy. This wasn't completed when the FDA reported. No data is in this report though. Otherwise it's the same data basis...3/n
...Known & unknown safety risks judged within acceptable range. Identified anaphylaxis as a risk, & potential for vaccine-associated enhanced respiratory disease listed. Here's TGA's list of safety unknowns needing more clinical data...4/n
...Lists pharmacovigilance studies internationally. Incl safety/immunogenicity in 150 immunosuppressed people, flu vax co-administered, & people hospitalized with possible Covid-19. See EU: ema.europa.eu/en/documents/r… No Aust studies planned tho no data for Aust indigenous people. /5

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Hilda Bastian, PhD

Hilda Bastian, PhD Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @hildabast

26 Jan
Meanwhile, a few days ago the EMA published its EPAR (public assessment report) on the Moderna vax (HT @pajz_) ema.europa.eu/en/documents/a… It's 169 pages ...1/n
...There was "a major objection" to the US manufacturing sites, so they were withdrawn. Complete transfer for Europe to Swiss manufacturing due to conclude soon. (There have been Qs in the US about a batch there reuters.com/article/us-hea…)...2/n Image
...If you're interested in the chemical & biological aspects of this vaccine, there are pages for you to dig into - not an area I have any expertise in. Small amount of detail of reproductive toxicity study (in rats): no cause for concern....3/n
Read 10 tweets
25 Jan
It's on the agenda this week: possibly a decision on the Oxford/AstraZeneca vaccine from EMA's (Euro drug regulator) Human Medicine Committee? Applicants will be questioned at the meeting.

(EMA process steps explained here: ema.europa.eu/en/human-regul…)
Last night, I tweeted ⬆️ that the EMA (Euro drug regulator) meeting was considering the Oxford/AstraZeneca vaccine. I included a link to EMA processes, because the language on the agenda suggested there could be a problem: this is the explanation I mean in that link ....1/n Image
...German newspapers now reporting a claim the efficacy rate for people over 65 is only 8% & approval is indeed in question for that age group, at least (Paywalls: I can't read in full.) Rumor at this point, but a limit ...2/n bild.de/bild-plus/poli…, handelsblatt.com/politik/deutsc…
Read 12 tweets
22 Jan
For everyone else who's on ENSEMBLE-Watch - the big J&J trial for their Ad26.COV2.S vaccine - some background & context in case a press release lands soon. (On Wednesday, Stanford got the word to lock their data abc7news.com/johnson-and-va… so it is on!)...1/5
...It's a big trial - close to the size of the Pfizer trial for Tozinameran, substantially bigger than Moderna's - & the most international one. And co-primary endpoints are for moderate to severe Covid-19, including 1 at a month - which is longer than we've seen previously...2/5
...You can see the protocol for the trial here: jnj.com/coronavirus/co… (Note, it was originally for 60,000 but they got so many events it was cut back to 40)...3/5
Read 6 tweets
20 Jan
Sputnik V news: ANMAT, Argentina's drug regulator, has now extended authorization to people 60+ & released some data this time. Here's the listing of what they've received & analyzed (but it's not published) ... 1/n argentina.gob.ar/noticias/ampli…
...The new data on people 60+ they received: in 2,144 people, vaccine efficacy of 91.8% (95% CI 67.1% -98.3%). Almost all those people had antibodies by 28 days ...2/n
...ANMAT reports there's now data for 19,866 people who received both Sputnik V injections, with no serious adverse events (SAEs) judged to be vaccine-related. There were 47 SAEs in vax group vs 23 in placebo. Safety similar for older people in small safety study. 3/3
Read 4 tweets
17 Jan
After 10s of thousands of Brazilians participated in early trials of Covid vaccine, vaccination has at last begun there: Anvisa (drug regulator) approved Sinovac's CoronaVac & Serum Institute of India's Covishield (Oxford/AstraZeneca vaccine) ...1/n g1.globo.com/sp/sao-paulo/n…
...Before I get to the Anvisa documentation, important update on the alligator tracker: jacare-tracker.org It's tracking Brazilian as well as global vaccinations & it's now on Twitter too @jacaretracker ...2/n
...Anvisa's documentation is here & includes trial data as well as manufacturing standards reports: gov.br/anvisa/pt-br/a…

CoronaVac data for the Brazilian trial only. 12,123 people in the whole trial: 64.3% female, 4.9% 60 years or older. Median age: 37 (for Pfizer: 52)...3/n
Read 13 tweets
16 Jan
Oh my... Remembering this time 4 years ago. I was living in DC. I flew back in the night before the inauguration with my 2-yr visa freshly updated: its expiration was my personal deadline to be living back in Oz. Taxi from airport was the first clue of what was coming...
...So many barricades & security, taxi from the airport had to try many routes to get me to my apartment in the middle of DC. Lots of Trump supporters whooping it up. But there were so many women, too....
...Dragged myself, mega-jetlagged, out to the Women's March - and women were streaming everywhere. I'd been to big demonstrations before, but I never saw one as big as this...
Read 5 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!